Intrinsic value of Corcept Therapeutics Incorporated (CORT)

[per Chepakovich valuation model]

other valuations of CORT

[per Chepakovich valuation model]  See other valuations of CORT stock

Previous Close$20.29
Intrinsic Value
Upside potential
Previous Close
$20.29

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-12-31 and quarterly data as of 2021-03-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %15.5NaN
Revenue, $354NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m226NaN
Operating income, $m128NaN
EBITDA, $m132NaN
Interest expense (income), $mNaN
Earnings before tax, $m132NaN
Tax expense, $m26NaN
Net income, $m106NaN

BALANCE SHEET

Cash and short-term investments, $m441NaN
Total assets, $m572NaN
Adjusted assets (=assets-cash), $m131NaN
Average production assets, $m2NaN
Working capital, $m431NaN
Total debt, $m0NaN
Total liabilities, $m48NaN
Total equity, $m523NaN
Debt-to-equity ratio0.000NaN
Adjusted equity ratio0.631NaN

CASH FLOW

Net income, $m106NaN
Depreciation, amort., depletion, $m4NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m152NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1NaN
Free cash flow, $m153NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m431
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN